相似文献
1
PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin.
Antimicrob Agents Chemother. 2002 Apr;46(4):1156-7. doi: 10.1128/AAC.46.4.1156-1157.2002.
2
3
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.
J Clin Microbiol. 2000 Feb;38(2):923-5. doi: 10.1128/JCM.38.2.923-925.2000.
4
Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan.
J Gastroenterol Hepatol. 2000 Aug;15(8):906-9. doi: 10.1046/j.1440-1746.2000.02072.x.
5
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori.
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):162-4. doi: 10.1007/BF01709478.
6
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.
J Clin Microbiol. 2001 Feb;39(2):691-5. doi: 10.1128/JCM.39.2.691-695.2001.
7
Detection of clarithromycin-resistant Helicobacter pylori strains in a dyspeptic patient population in Sri Lanka by polymerase chain reaction-restriction fragment length polymorphism.
Indian J Med Microbiol. 2015 Jul-Sep;33(3):374-7. doi: 10.4103/0255-0857.158557.
8
Clarithromycin-susceptible Helicobacter pylori with mutation in 23S rRNA gene by PCR-RFLP method.
J Gastroenterol. 2000;35(4):315-6. doi: 10.1007/s005350050354.
9
Clarithromycin resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Malaysia.
J Dig Dis. 2010 Apr;11(2):101-5. doi: 10.1111/j.1751-2980.2010.00423.x.
10
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.
J Antimicrob Chemother. 1997 Aug;40(2):283-6. doi: 10.1093/jac/40.2.283.
引用本文的文献
1
Detection of A2143G, A2142C, and A2142G Point Mutations with Real-Time PCR in Stool Specimens from Children Infected with .
Diagnostics (Basel). 2022 Aug 31;12(9):2119. doi: 10.3390/diagnostics12092119.
2
Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Next Generation Sequencing Data.
Biomolecules. 2022 May 11;12(5):691. doi: 10.3390/biom12050691.
3
Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, Iran.
BMC Res Notes. 2021 May 31;14(1):216. doi: 10.1186/s13104-021-05633-5.
4
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17.
5
Analysis of Correlation between the Seven Important (. ) Virulence Factors and Drug Resistance in Patients with Gastritis.
Gastroenterol Res Pract. 2020 Aug 29;2020:3956838. doi: 10.1155/2020/3956838. eCollection 2020.
6
Trends in resistance to clarithromycin: from phenotypic to genomic approaches.
Microb Genom. 2020 Mar;6(3). doi: 10.1099/mgen.0.000344.
7
Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania.
Can J Gastroenterol Hepatol. 2019 Jul 1;2019:8481375. doi: 10.1155/2019/8481375. eCollection 2019.
8
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study.
BMC Infect Dis. 2019 May 21;19(1):447. doi: 10.1186/s12879-019-4085-1.
9
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.
World J Gastroenterol. 2017 Sep 21;23(35):6379-6384. doi: 10.3748/wjg.v23.i35.6379.
10
Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication.
Asian Pac J Cancer Prev. 2017 Apr 1;18(4):927-932. doi: 10.22034/APJCP.2017.18.4.927.
本文引用的文献
1
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study.
Antimicrob Agents Chemother. 2001 May;45(5):1500-4. doi: 10.1128/AAC.45.5.1500-1504.2001.
2
PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples.
J Clin Microbiol. 2001 Apr;39(4):1217-20. doi: 10.1128/JCM.39.4.1217-1220.2001.
3
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.
J Clin Microbiol. 2001 Feb;39(2):691-5. doi: 10.1128/JCM.39.2.691-695.2001.
4
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori.
J Clin Microbiol. 1999 Nov;37(11):3746-8. doi: 10.1128/JCM.37.11.3746-3748.1999.
5
Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance.
Antimicrob Agents Chemother. 1999 Jul;43(7):1779-82. doi: 10.1128/AAC.43.7.1779.
6
Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens.
Gut. 1999 Apr;44(4):463-7. doi: 10.1136/gut.44.4.463.
7
Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase.
J Clin Microbiol. 1998 Nov;36(11):3285-90. doi: 10.1128/JCM.36.11.3285-3290.1998.
8
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.
Antimicrob Agents Chemother. 1997 Dec;41(12):2724-8. doi: 10.1128/AAC.41.12.2724.
9
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.
Antimicrob Agents Chemother. 1997 Dec;41(12):2621-8. doi: 10.1128/AAC.41.12.2621.
10
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.
Antimicrob Agents Chemother. 1997 Nov;41(11):2550-3. doi: 10.1128/AAC.41.11.2550.
Zotero 插件